Results 141 to 150 of about 3,790 (190)

Pharmacokinetic Characterization of Labetalol in Pregnancy (The CLIP Study): A Prospective Observational Longitudinal Pharmacokinetic/Pharmacodynamic Cohort Study During Pregnancy and Postpartum. [PDF]

J Clin Med
Bhamidipaty-Pelosi S, Muralidharan S, Yeley BC, Haas DM, Quinney SK.   +4 more
europepmc   +1 more source

Seat Belt Aorta in a Paediatric Patient: Conservative Management with Eight Year Follow Up to Adulthood. [PDF]

EJVES Vasc Forum
Fourrier A, Nasr B, Hebert T, Espinasse B.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intravenous Labetalol and Intravenous Dihydralazine in Severe Hypertension in Pregnancy

Clinical and Experimental Hypertension Part B, Hypertension in Pregnancy, 1982
The effect of intravenous infusion of labetalol and of dihydralazine in increasing doses was compared in 12 women with severe hypertension in pregnancy. In 5 our of 6 women labetalol produced a smooth, progressive fall in blood pressure to normal levels with minimal side effects.
A, Garden, D A, Davey, J, Dommisse
exaly   +3 more sources

Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically Ill patients

Journal of Critical Care, 2012
Critically ill patients with acute hypertension often require titratable rapid blood pressure (BP) reductions using parenteral administration of drugs. There are few comparative studies available to make informed drug product selection decisions.
Mark A, Malesker, Daniel E, Hilleman
exaly   +3 more sources

Poor hypotensive response and tachyphylaxis following intravenous labetalol

Current Medical Research and Opinion, 1978
Three renal patients with transplant kidneys and uncontrolled hypertension were treated with intravenous doses of labetalol. Only minor depressor effects were noted and tachyphylaxis developed in 1 patient. Other parenteral hypotensive agents reduced blood pressure satisfactorily.
Roger Gabriel
exaly   +3 more sources

Efficacy and Safety of Intravenous Labetalol in Acute Hypertensive Crisis in Children

Indian Journal of Pediatrics, 2021
To determine the efficacy and safety of intravenous (IV) labetalol in the management of hypertensive crisis in children.A retrospective chart review of 56 consecutive children (age > 1 mo to ≤ 12 y) with hypertensive crisis admitted to a pediatric intensive care unit (PICU) from July 2009 to 2019.The proportion of children attaining the primary ...
Arun Bansal, , Muralidharan Jayashree
exaly   +3 more sources

The electrophysiological effects of intravenous Labetalol in man

European Journal of Clinical Pharmacology, 1981
A, Harley, H A, Coverdale
exaly   +3 more sources